Ralf Pasternack
Overview
Explore the profile of Ralf Pasternack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Heil A, Ohsam J, van Genugten B, Diez O, Yokoyama K, Kumazawa Y, et al.
J Agric Food Chem
. 2017 Jul;
65(32):6982-6990.
PMID: 28721717
The effect of standard bakery concentrations of microbial transglutaminase (MTG) in wheat bread preparation on the immunoreactivity of sera of celiac disease (CD) patients was investigated. Immunoblotting using monoclonal antibodies...
12.
van der Wildt B, Wilhelmus M, Kooijman E, Jongenelen C, Schuit R, Buchold C, et al.
Nucl Med Biol
. 2016 Nov;
44:90-104.
PMID: 27837727
Introduction: The protein-protein crosslinking activity of the enzyme tissue transglutaminase (TG2; EC 2.3.2.13) is associated with the pathogenesis of various diseases, including celiac disease, lung-, liver- and kidney fibrosis, cancer...
13.
Dodt J, Pasternack R, Seitz R, Volkers P
Br J Haematol
. 2015 Oct;
172(3):452-60.
PMID: 26516704
In a factor XIIIa (FXIIIa) generation assay with recombinant FXIII-A2 (rFXIII-A2 ) free FXIII activation peptide (fAP-FXII) prolonged the time to peak (TTP) but did not affect the area under...
14.
Ruh T, Ohsam J, Pasternack R, Yokoyama K, Kumazawa Y, Hils M
J Agric Food Chem
. 2014 Jul;
62(30):7604-11.
PMID: 24998318
The effect of microbial transglutaminase (MTG)-treatment of pasta-dough on the immunoreactivity with celiac disease patient's sera has been investigated. Modification by MTG has been proven by determination of the MTG...
15.
Stieler M, Weber J, Hils M, Kolb P, Heine A, Buchold C, et al.
Angew Chem Int Ed Engl
. 2013 Oct;
52(45):11930-4.
PMID: 24115223
No abstract available.
16.
Heil A, Weber J, Buchold C, Pasternack R, Hils M
Thromb Res
. 2013 Mar;
131(5):e214-22.
PMID: 23498170
Introduction: The A-subunit of blood coagulation factor XIII is a pro-transglutaminase, which cross-links α- and γ-fibrin-chains in its activated form. Selective inhibitors against FXIII-A may be desirable drugs to prevent...
17.
Elli L, Roncoroni L, Hils M, Pasternack R, Barisani D, Terrani C, et al.
Hum Immunol
. 2012 Jul;
73(10):992-7.
PMID: 22836039
Coeliac disease pathogenesis is characterized by an immune response triggered, in genetically predisposed subjects, by ingested gluten and its withdrawal from the diet is the only available therapy. However, enzymatic...
18.
McConoughey S, Basso M, Niatsetskaya Z, Sleiman S, Smirnova N, Langley B, et al.
EMBO Mol Med
. 2010 Jul;
2(9):349-70.
PMID: 20665636
Caused by a polyglutamine expansion in the huntingtin protein, Huntington's disease leads to striatal degeneration via the transcriptional dysregulation of a number of genes, including those involved in mitochondrial biogenesis....
19.
McConoughey S, Niatsetskaya Z, Pasternack R, Hils M, Ratan R, Cooper A
Anal Biochem
. 2009 Mar;
390(1):91-3.
PMID: 19306836
Aberrant transglutaminase (TG) activity has been implicated in the pathology of numerous diseases, including Huntington's disease and Alzheimer's disease. To fully characterize the role of TGs in these disorders, it...
20.
Oertel K, Hunfeld A, Specker E, Reiff C, Seitz R, Pasternack R, et al.
Anal Biochem
. 2007 Jun;
367(2):152-8.
PMID: 17582378
Based on the iso-peptidase activity of human plasma FXIII, a novel fluorometric assay that determines FXIII concentrations in human plasma below 0.05 IU/ml is introduced. We considered a peptide sequence...